retatrutide clinical trials results weight loss trial in 28 percent average Clinical trial results for retatrutide,

As GLP-1RA usage continues to grow worldwide, multidisciplinary cooperation between endocrinologists, otolaryngologists, and vestibular experts will ultimately be crucial to better understanding and treating this developing safety issue

a 92% reduction in diabetes deaths, 60% reduction in cancer deaths, 56% reduction in coronary artery disease deaths and 40% reduction in all-cause mortality was demonstrated in a retrospective matched cohort study of obese individuals undergoing bariatric surgery

Dry eye in diabetic patients

!Safety note The FDA has reviewed reports of suicidal thoughts or actions with GLP-1 receptor agonists and, in 2026, requested removal of suicidal ideation and behavior warning language from affected GLP-1 labels after finding no increased risk

Their ability to replace traditional mechanical fasteners like screws, bolts, and rivets has positioned foam tapes as a preferred solution in

Another meta-analysis on pancreatic cancer specifically also showed that GLP-1RAs were not associated with increased risk for pancreatic cancer as compared with other treatments (93)